This 3-day certification program is designed to educate healthcare practitioners—both the novices and regular prescribers – on a variety of related topics based on the latest scientific evidence and clinical research. Primary topics incorporated throughout the program will include the major phytocannabinoids, cannabidiol (CBD), and delta-9-tetrahydrocannabinol (Δ9-THC) found in marijuana and hemp plants.
Alex Capano, DNP, CRNP, FNP-BC, is the Chief Science Officer of Ecofibre Limited, the global leader in hemp technologies that provides innovation solutions to address emerging health and resource sustainability issues.
At Ecofibre, Dr. Capano champions the company’s $40 million commitment to research to advance the clinical evidence of hemp extract. Ecofibre was the first hemp company to receive IND authorization from the FDA for research. Partnering with leading healthcare and academic institutions, Dr. Capano is currently researching CBD’s effects on CIPN, sleep, anxiety, addiction, endometriosis, certain cancers, and cognitive decline.